Eli Lilly and Company (NYSE: LLY) today announced it will present 16 abstracts at the 2026 Alzheimer's Association ...
A simulation of future astronaut moon bases suggests that mission design, and not just psychology, needs to be considered for ...
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ...
Deaths from snake bites may be much rarer than earlier estimated, according to an 11-state survey funded by the Indian ...
Our researchers imagine what the world might look like in 2076, when the university celebrates its bicentennial ...
Morning Overview on MSN
A common diabetes drug is showing signs of slowing aging in people
Metformin, a drug prescribed to tens of millions of people with type 2 diabetes, is producing measurable shifts in molecular ...
Morning Overview on MSN
Seven years on, most lung cancer patients on one drug had no progression
More than half of patients with advanced ALK-positive lung cancer who started on lorlatinib seven years ago still have not ...
As the adoption of medical AI rapidly grows, healthcare AI companies are shifting from simply generating answers to proving why those answers should be trusted. OpenEvidence, an AI-powered medical ...
Modern hip replacements could change what patients expect from surgery. Instead of a temporary fix, they may offer decades of ...
Initiatives like UofL's Green Heart Project relies on an assumption that trees operate like medicine, but this enthusiasm has had real consequences.
Biosimilar anti-VEGF agents matched the reference ranibizumab in vision outcomes and safety across retinal diseases in India, at a lower cost. More than half of India's health care spending is paid ...
Like a chameleon changing its colour to better suit its environment, the DS No 7 is the brand’s latest step towards better fitting the premium SUV market. As something to drive normally in, the No 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results